PTPRC and non-small cell lung carcinoma: Until recently, neutrophils were only regarded as bystanders in cancer [90], however, they constituted 20% of all CD45+ cells in non–small-cell lung cancer (NSCLC) tumor specimens, thus representing a major immune cell type in NSCLC [91].